The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Boston Scientific Corp (NYSE:BSX), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).
The investment seeks long-term capital appreciation.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.
The average market capitalization across the Hartford Healthcare Y MF is 153.85B. The market cap for tickers in the group ranges from 39.59B to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is CNC at 39.59B.
The average weekly volume growth across all stocks in the Hartford Healthcare Y MF was 19%. For the same stocks of the MF, the average monthly volume growth was 16% and the average quarterly volume growth was 30%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 46
P/E Growth Rating: 54
Price Growth Rating: 49
SMR Rating: 57
Profit Risk Rating: 41
Seasonality Score: 9 (-100 ... +100)